Information for healthcare professionals on Guillain-Barré Syndrome (GBS) following COVID-19 vaccination. Category: UncategorisedBy 20 August 2021Leave a commentPost navigationPreviousPrevious post:Guidance: SCID screening evaluation: checklists for immunology servicesNextNext post:Press release: Government data shows mass events can take place safely but fans urged to remain cautious in crowds and get vaccinated